Status:
COMPLETED
Measuring Non-Enhancing Glioblastoma Progression
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Brain Tumor
Glioblastoma
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this clinical research study is to learn if magnetic resonance imaging with magnetic resonance spectroscopy ("MRI/MRS" scanning) can measure any extra growth in the tumor that does not sho...
Detailed Description
The Study Procedures: MRI scanning is commonly used to check the status of glioblastoma. In this study, MRI scanning will also be used to try to better understand how chemotherapy that blocks blood v...
Eligibility Criteria
Inclusion
- Patients with histologically proven intracranial glioblastoma or gliosarcoma will be eligible for this protocol
- Patients with recurrent glioblastoma or gliosarcoma who are scheduled to start systemic chemotherapy with bevacizumab.
- Patients tumor must be located in an area that is amenable to the proposed imaging sequences.
- Patients must be age 18 or older.
- Karnofsky Performance Status Scale (KPS) \>/= 70.
- Inclusion of Women and Minorities: Both men and women and members of all races and ethnic groups are eligible for this trial.
- Patients must sign an informed consent indicating that they are aware of the investigational nature of the study in keeping with the policies of the hospital. The only acceptable consent form is the one attached at the end of this protocol.
Exclusion
- Patients with histologically proven intracranial glioblastoma or gliosarcoma will be eligible for this protocol
- Patients with recurrent glioblastoma or gliosarcoma who are scheduled to start systemic chemotherapy with bevacizumab.
- Patients tumor must be located in an area that is amenable to the proposed imaging sequences.
- Patients must be age 18 or older.
- KPS \>/= 70.
- Inclusion of Women and Minorities: Both men and women and members of all races and ethnic groups are eligible for this trial.
- Patients must sign an informed consent indicating that they are aware of the investigational nature of the study in keeping with the policies of the hospital.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00777686
Start Date
August 1 2008
End Date
March 1 2011
Last Update
March 30 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030